{"log_id": 4503053311265839974, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0.030321, "average": 0.935158, "min": 0.413548}, "location": {"width": 192, "top": 299, "height": 27, "left": 200}, "words": "3、龄妇女与致畸性"}, {"probability": {"variance": 8e-05, "average": 0.996028, "min": 0.952711}, "location": {"width": 733, "top": 325, "height": 31, "left": 241}, "words": "这种药不应该在育龄妇女中使用,除非明确需要(即在其他治疗无效或不能耐受"}, {"probability": {"variance": 0, "average": 0.999943, "min": 0.999943}, "location": {"width": 24, "top": 357, "height": 26, "left": 219}, "words": "况"}, {"probability": {"variance": 0.008028, "average": 0.975382, "min": 0.519886}, "location": {"width": 579, "top": 356, "height": 31, "left": 374}, "words": "估要在第一次开本品的处方之前或者一个用本品进行治疗的育龄"}, {"probability": {"variance": 0.00048, "average": 0.989386, "min": 0.922763}, "location": {"width": 231, "top": 385, "height": 27, "left": 225}, "words": "划怀孕时进行。育龄妇女"}, {"probability": {"variance": 0.005264, "average": 0.968436, "min": 0.748591}, "location": {"width": 249, "top": 385, "height": 27, "left": 539}, "words": "疗期间使用有效的避孕方法"}, {"probability": {"variance": 0.000241, "average": 0.995874, "min": 0.899377}, "location": {"width": 752, "top": 423, "height": 25, "left": 237}, "words": "根据已经发表的和未发表的报告,丙戊酸可能对在怀孕期间应用该药物的妇女的后代产生致畸"}, {"probability": {"variance": 0.000127, "average": 0.993548, "min": 0.952616}, "location": {"width": 789, "top": 461, "height": 26, "left": 201}, "words": "效应。丙戊酸钠可能会产生诸如神经管缺陷之类的致畸效应(比如:脊柱裂)。因此,只有治疗的"}, {"probability": {"variance": 0.001172, "average": 0.992159, "min": 0.775743}, "location": {"width": 789, "top": 498, "height": 25, "left": 202}, "words": "受益性大于对胎儿伤害的危险性时,才能在育龄妇女中应用。(参见【孕妇及哺乳期妇女用药】中"}, {"probability": {"variance": 0.001139, "average": 0.975794, "min": 0.928065}, "location": {"width": 51, "top": 537, "height": 21, "left": 201}, "words": "内容)"}, {"probability": {"variance": 0.000592, "average": 0.987984, "min": 0.913874}, "location": {"width": 227, "top": 609, "height": 24, "left": 202}, "words": "4、尿素循环障碍疾病(UCD"}, {"probability": {"variance": 0.004353, "average": 0.987919, "min": 0.586859}, "location": {"width": 698, "top": 633, "height": 24, "left": 202}, "words": "存在尿素循环酶缺陷的患者不推荐使用本品。尿素循环障碍疾病是一组不常见的遗传异"}, {"probability": {"variance": 0.005628, "average": 0.984591, "min": 0.503175}, "location": {"width": 788, "top": 657, "height": 24, "left": 204}, "words": "常疾病,特别见于鸟氨酸氨甲酰基转移酶缺陷的情况下。在这些患者中曾有高氨血症导致的昏迷的"}, {"probability": {"variance": 1.3e-05, "average": 0.996512, "min": 0.990717}, "location": {"width": 130, "top": 684, "height": 21, "left": 203}, "words": "散发病例的报道"}, {"probability": {"variance": 0.003013, "average": 0.983209, "min": 0.726616}, "location": {"width": 786, "top": 728, "height": 25, "left": 205}, "words": "在下列患者中,在开始应用本品之前,应该考虑对UCD进行评估,这些患者是:1)具有不明原因的"}, {"probability": {"variance": 0.009602, "average": 0.967321, "min": 0.475079}, "location": {"width": 752, "top": 754, "height": 22, "left": 203}, "words": "脑病或者昏迷病史的患者、具有与蛋白质负荷相关的脑病病史的患者、具有与怀孕相关性脑病"}, {"probability": {"variance": 0.012623, "average": 0.964196, "min": 0.392572}, "location": {"width": 795, "top": 774, "height": 28, "left": 204}, "words": "后脑病病史的患者、具有血浆氨或谷氨酸盐水平增高病史的患者;2)那些具有环性呕吐偶发"}, {"probability": {"variance": 0.007776, "average": 0.969899, "min": 0.505703}, "location": {"width": 795, "top": 802, "height": 24, "left": 204}, "words": "生的极度兴奋性、运动性共济失调、低BUN或蛋白质回避的患者;3)具有UCD家族史的患者或具有"}, {"probability": {"variance": 0.009128, "average": 0.969219, "min": 0.468076}, "location": {"width": 785, "top": 825, "height": 27, "left": 206}, "words": "不明原因的婴儿死亡(特别是男孩)家族史的患者;4)那些具有其它UCD体征利症状的患者。在接"}, {"probability": {"variance": 0.011641, "average": 0.963353, "min": 0.461755}, "location": {"width": 762, "top": 850, "height": 26, "left": 205}, "words": "受本品治疗时出现不明原因的高血氨性脑病的患者应该立即接受治疗(包括格班丙戊酸钠治疗)"}, {"probability": {"variance": 5e-06, "average": 0.998655, "min": 0.990567}, "location": {"width": 332, "top": 879, "height": 21, "left": 205}, "words": "并且对潜在的尿素循环障碍疾病进行评估"}, {"probability": {"variance": 1.3e-05, "average": 0.997672, "min": 0.988372}, "location": {"width": 200, "top": 926, "height": 23, "left": 205}, "words": "5、在老年患者中的嗜睡"}, {"probability": {"variance": 0.006189, "average": 0.972097, "min": 0.663744}, "location": {"width": 789, "top": 945, "height": 28, "left": 205}, "words": "在老年患者中,给药剂量应该更加缓慢地增加,并且规律性地对液体和营养物质的微取能水、嗜"}, {"probability": {"variance": 0.000242, "average": 0.993202, "min": 0.935119}, "location": {"width": 433, "top": 977, "height": 22, "left": 206}, "words": "睡以及其它不良事件进行监测(参见【用量和用法】"}, {"probability": {"variance": 7.1e-05, "average": 0.992554, "min": 0.977798}, "location": {"width": 141, "top": 1026, "height": 24, "left": 206}, "words": "6、血小板减少症"}, {"probability": {"variance": 0.007681, "average": 0.98034, "min": 0.420416}, "location": {"width": 797, "top": 1050, "height": 24, "left": 206}, "words": "在双丙戊酸治疗中已经报道才发生血小板减少症、由于该药物对血小板聚合的第2阶段的制、以及"}, {"probability": {"variance": 5.7e-05, "average": 0.997169, "min": 0.955385}, "location": {"width": 783, "top": 1076, "height": 23, "left": 210}, "words": "凝血参数的异常(比如:低纤维蛋白原),所以推荐在开始治疗之前和周期性的间期内,对血小板"}, {"probability": {"variance": 9e-06, "average": 0.998488, "min": 0.98941}, "location": {"width": 205, "top": 1102, "height": 21, "left": 207}, "words": "计数和凝血功能进行检测"}, {"probability": {"variance": 0, "average": 0.74168, "min": 0.74168}, "location": {"width": 50, "top": 1104, "height": 25, "left": 729}, "words": " PHAR"}, {"probability": {"variance": 3.1e-05, "average": 0.996132, "min": 0.984758}, "location": {"width": 161, "top": 1150, "height": 24, "left": 207}, "words": "7、在孕妇中的应用"}, {"probability": {"variance": 0.000698, "average": 0.975997, "min": 0.938654}, "location": {"width": 136, "top": 1133, "height": 44, "left": 705}, "words": "杭州)"}, {"probability": {"variance": 0.007649, "average": 0.981465, "min": 0.424488}, "location": {"width": 769, "top": 1195, "height": 27, "left": 208}, "words": "根据已经发表的和未发表的报告,丙戊酸可能对在怀孕期应用该药物的妇女的后代产生致畸效"}, {"probability": {"variance": 0, "average": 0.956394, "min": 0.956394}, "location": {"width": 20, "top": 1226, "height": 18, "left": 208}, "words": "应"}, {"probability": {"variance": 0.005926, "average": 0.976544, "min": 0.581789}, "location": {"width": 770, "top": 1266, "height": 28, "left": 208}, "words": "在怀孕的前三个月接受丙戊酸钠治疗的母亲中,她们的胎儿出现神经管缺陷的发生率可能会增高"}, {"probability": {"variance": 0.001577, "average": 0.989679, "min": 0.749251}, "location": {"width": 791, "top": 1292, "height": 24, "left": 207}, "words": "美国国家疾病控制中心(CDC)已经确定,对丙戊酸暴露的妇女的孩子出现脊柱裂的危险性大约为"}, {"probability": {"variance": 1.2e-05, "average": 0.997762, "min": 0.991857}, "location": {"width": 64, "top": 1320, "height": 20, "left": 210}, "words": "%到2%"}, {"probability": {"variance": 2.4e-05, "average": 0.996955, "min": 0.973824}, "location": {"width": 789, "top": 1364, "height": 24, "left": 208}, "words": "已经报告了其它先天性异常(比如:颅面部缺陷、心血管畸形以及涉及多个身体系统的异常),这"}, {"probability": {"variance": 0.002257, "average": 0.988094, "min": 0.697543}, "location": {"width": 786, "top": 1388, "height": 25, "left": 211}, "words": "些先天性异常可以与生命共存,也可能不能与生命共存。尚没有足够的数据来确定这些先天性异常"}, {"probability": {"variance": 7.1e-05, "average": 0.993422, "min": 0.978918}, "location": {"width": 75, "top": 1416, "height": 20, "left": 209}, "words": "的发生率"}, {"probability": {"variance": 3.7e-05, "average": 0.993626, "min": 0.982747}, "location": {"width": 173, "top": 1479, "height": 28, "left": 541}, "words": "第6页共14页"}], "language": 3}